Diverse Technology Portfolio Expression Analysis utilizes a broad range of advanced sequencing and genotyping platforms, including Affymetrix, Illumina, Pacific Biosciences, and RainDance Technologies, indicating a strong capability to support projects with diverse technological requirements.

Specialized Sample Handling The company offers solutions for challenging specimen types such as whole blood and FFPE tissues, which presents opportunities to assist clients working with difficult or degraded samples needing expert processing and analysis.

Quality Compliance Following CLSI guidelines and holding CLIA registration with GLP support, Expression Analysis appeals to clients requiring high-quality, regulatory-compliant data, making it an attractive partner for clinical and translational research collaborations.

Growth Potential With a revenue range between 1 million and 10 million and a relatively small team, the company presents opportunities for scalable service expansion and strategic partnerships aimed at increasing market share in niche genomics services.

Market Positioning Operating in the biotechnology research sector with comparable firms of similar size and specialization, Expression Analysis is well-positioned to target research institutions and pharma companies seeking comprehensive gene expression and sequencing solutions.